Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study

BACKGROUND: As the novel serum biomarkers, it has not been clearly clarified that the diagnostic accuracy of prostate health index (PHI) and prostate health index density (PHID) are superior to that of percentage free prostate-specific antigen (%fPSA) in detection of clinically significant prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bo, Shao, Yuan, Lin, Xueming, Hasi, Chaolu, Jia, Wei, Wang, Dongwen, Cao, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080357/
https://www.ncbi.nlm.nih.gov/pubmed/37032752
http://dx.doi.org/10.21037/tau-23-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080357/
https://www.ncbi.nlm.nih.gov/pubmed/37032752
http://dx.doi.org/10.21037/tau-23-80

Ejemplares similares